349 related articles for article (PubMed ID: 35928878)
1. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
Front Oncol; 2022; 12():895413. PubMed ID: 35928878
[TBL] [Abstract][Full Text] [Related]
2. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
3. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
Li Y; Chen T; Fu B; Luo Y; Chen L
Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database.
Zhan X; Jiang M; Deng W; Liu X; Chen L; Fu B
Front Oncol; 2022; 12():789028. PubMed ID: 35186736
[TBL] [Abstract][Full Text] [Related]
6. Nomogram Based on Log Odds of Positive Lymph Nodes Predicting Cancer-Specific Survival in Patients With T3 and T4 Gallbladder Cancer After Radical Resection.
Yuan C; Tao Q; Wang J; Wang K; Zou S; Hu Z
Front Surg; 2021; 8():675661. PubMed ID: 34778352
[No Abstract] [Full Text] [Related]
7. Development and validation of prognostic nomogram based on log odds of positive lymph nodes for patients with gastric signet ring cell carcinoma.
Xu Z; Jing J; Ma G
Chin J Cancer Res; 2020 Dec; 32(6):778-793. PubMed ID: 33447000
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and Predictive Model of the Log Odds of the Negative Lymph Node/T Stage Ratio in Resectable Gastric Adenocarcinoma Patients.
Yang W; Lu S; Ge F; Hua Y; Chen X
J Gastrointest Surg; 2022 Aug; 26(8):1743-1756. PubMed ID: 35831692
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study.
Xia Y; Liu X; Ma B; Huang T; Xu D; Zhao C
Am J Clin Exp Urol; 2023; 11(6):500-515. PubMed ID: 38148935
[TBL] [Abstract][Full Text] [Related]
10. A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy.
Yang J; Huang H; Li W; Ran S; Hu J; Zhang Y; Li W; Chen C; He W
Curr Oncol; 2022 Sep; 29(10):6834-6846. PubMed ID: 36290816
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery.
Li R; Lu Z; Sun Z; Shi X; Li Z; Shao W; Zheng Y; Song J
Front Surg; 2021; 8():757552. PubMed ID: 34765638
[No Abstract] [Full Text] [Related]
12. Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.
Chen F; Long H; Ding J; Ren J; Qu B; Cao P; Wang Z; Wu Z; Ma Q; Ma Z
Am J Cancer Res; 2023; 13(12):5825-5845. PubMed ID: 38187057
[TBL] [Abstract][Full Text] [Related]
13. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
14. A postsurgical prognostic nomogram for patients with lymph node positive rectosigmoid junction adenocarcinoma.
Yanlong W; Yunxiao W; Yibing W
BMC Gastroenterol; 2023 May; 23(1):159. PubMed ID: 37202718
[TBL] [Abstract][Full Text] [Related]
15. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study.
Ye W; Wang Q; Lu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13607-13618. PubMed ID: 37515614
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.
Li J; Cui T; Huang Z; Mu Y; Yao Y; Xu W; Chen K; Liu H; Wang W; Chen X
Front Oncol; 2023; 13():1062142. PubMed ID: 37007147
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study.
Wang W; Liu J; Liu L
Front Oncol; 2021; 11():692728. PubMed ID: 34222021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
